View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
January 22, 2020updated 13 Feb 2020 10:27am

Coronavirus: CDC confirms first US case; search for cure underway

The Centers for Disease Control and Prevention (CDC) in the US has reported the first case of the new coronavirus, named 2019-nCoV, in a man who returned from Wuhan city of China to Washington.


Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Free Report
img

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

Follow the latest updates of the outbreak on our timeline.

The Centers for Disease Control and Prevention (CDC) in the US has reported the first case of the new coronavirus, named 2019-nCoV, in a man who returned from Wuhan city of China to Washington.

The US patient returned to the country on 15 January, with infection confirmation taking place on 21 January. The patient is assumed to be relatively healthy, now isolated at a medical centre as a precaution.

Following the report, the Dow and broader stock market saw a drop in the stock.

While the risk to the general public is low, US officials have been preparing to address a potential outbreak in the country.

In addition to alerting clinicians and screening at airports, CDC is developing a diagnostic test to identify the virus in clinical specimens. The organisation intends to share the tests to partners globally in the coming weeks.

On 16 January, the German Center for Infection Research (DZIF) at Charité – Universitätsmedizin Berlin researchers announced the development of the first diagnostic assay to detect the virus. The laboratory test has been made publicly available and is in a joint evaluation study by an international consortium.

Coronavirus symptoms are similar to those caused by flu, such as pneumonia. The virus has been linked to a seafood market in Wuhan, where the outbreak began. Death toll from the virus has increased to nine as of 21 January, said Chinese officials.

Alongside China, cases of the new coronavirus have been reported in Thailand, Japan and Korea. On 21 January, Taiwan reported the first case of coronavirus infection in a woman who returned from Wuhan.

Related Companies

Free Report
img

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU